Year |
Citation |
Score |
2010 |
Watanabe J, Lin JA, Narasimha AJ, Shahbazian A, Ishikawa TO, Martin MG, Herschman HR, Reddy ST. Novel anti-inflammatory functions for endothelial and myeloid cyclooxygenase-2 in a new mouse model of Crohn's disease. American Journal of Physiology. Gastrointestinal and Liver Physiology. 298: G842-50. PMID 20299600 DOI: 10.1152/Ajpgi.00468.2009 |
0.522 |
|
2010 |
Narasimha AJ, Watanabe J, Ishikawa TO, Priceman SJ, Wu L, Herschman HR, Reddy ST. Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 260-8. PMID 19926832 DOI: 10.1161/Atvbaha.109.198762 |
0.438 |
|
2008 |
Buga GM, Frank JS, Mottino GA, Hakhamian A, Narasimha A, Watson AD, Yekta B, Navab M, Reddy ST, Anantharamaiah GM, Fogelman AM. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. Journal of Lipid Research. 49: 192-205. PMID 17925450 DOI: 10.1194/Jlr.M700433-Jlr200 |
0.363 |
|
2007 |
Lin JA, Watanabe J, Rozengurt N, Narasimha A, Martin MG, Wang J, Braun J, Langenbach R, Reddy ST. Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice. Prostaglandins & Other Lipid Mediators. 84: 98-107. PMID 17991612 DOI: 10.1016/J.Prostaglandins.2007.04.004 |
0.496 |
|
2007 |
Narasimha A, Watanabe J, Lin JA, Hama S, Langenbach R, Navab M, Fogelman AM, Reddy ST. A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors. Prostaglandins & Other Lipid Mediators. 84: 24-33. PMID 17643885 DOI: 10.1016/J.Prostaglandins.2007.03.004 |
0.418 |
|
Show low-probability matches. |